| Identification | Back Directory | [Name]
Sorafenib Impurity 13 | [CAS]
583840-04-4 | [Synonyms]
BAY 68-7769
Sorafenib Impurity 44
Sorafenib N-Desmethyl N-Oxide
N-Desmethyl Sorafenib (Pyridine)-N-oxide
Sorafenib Impurity 44(Sorafenib N-Desmethyl N-Oxide)
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-, 1-oxide | [Molecular Formula]
C20H14ClF3N4O4 | [MOL File]
583840-04-4.mol | [Molecular Weight]
466.8 |
| Chemical Properties | Back Directory | [InChI]
InChI=1S/C20H14ClF3N4O4/c21-16-6-3-12(9-15(16)20(22,23)24)27-19(30)26-11-1-4-13(5-2-11)32-14-7-8-28(31)17(10-14)18(25)29/h1-10H,(H2,25,29)(H2,26,27,30) | [InChIKey]
VYTLLTTWWZIYME-UHFFFAOYSA-N | [SMILES]
C1(C(N)=O)[N+]([O-])=CC=C(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C=C2)C=1 |
| Hazard Information | Back Directory | [Uses]
N-Desmethyl Sorafenib (Pyridine)-N-oxide is a metabolite of Sorafenib (S676850) and has anti-proliferative activity in human breast cancer cells. |
|
| Company Name: |
Roark Standards
|
| Tel: |
0755-83552066 15986688328 |
| Website: |
roarkstandards.com |
|